From Sweden: Risk for Esophageal Adenocarcinoma Not Increased With Nonerosive GERD
From Sweden: Risk for Esophageal Adenocarcinoma Not Increased With Nonerosive GERD
Patients with nonerosive gastroesophageal reflux disease (GERD) do not have an increased risk for esophageal adenocarcinoma compared with the general population, according to a study published online Sept. 13 in The BMJ.
Dag Holmberg, M.D., Ph.D., from Karolinska Institutet in Stockholm, and colleagues conducted a population-based cohort study to examine the incidence rate of esophageal adenocarcinoma among patients with nonerosive GERD versus the general population. A total of 486,556 adults who underwent endoscopy were included: 285,811 were included in the nonerosive GERD cohort and 200,745 were in the validation cohort with erosive GERD.
Source: Advances and More licensed by HealthDay
https://advancesandmore.com/advances_article.htm?id=2665383997&client=BEE80FAF§ion=undefined
